OneMedNet’s Stock Skyrockets After Securing Deal with Global Healthcare Giant

  • OneMedNet’s shares soar 54% after signing a new contract with a top-10 global medical technology company
  • The company has a three-year master services agreement with a US-based firm serving over 150 million patients worldwide
  • OneMedNet will use its iRWD platform to securely de-identify, search and curate clinical data for the new customer’s subsidiaries and affiliates

OneMedNet, a health-care data company, saw its shares surge by 54% to $3.01 after announcing a new contract with an undisclosed global top-10 medical technology provider. The stock had closed the regular session down 3%. This year, OneMedNet’s shares have increased by 141%. The non-exclusive three-year master services agreement involves using its proprietary iRWD platform to manage data for the company’s worldwide subsidiaries and affiliates under a fee-for-service model. Based in Minneapolis, OneMedNet specializes in curating regulatory-grade Real World Data, including electronic health records and medical imaging.

Factuality Level: 8
Factuality Justification: The article provides accurate information about a company’s stock performance and its new contract with an unnamed global top-10 medical technology provider. It also explains the services provided by OneMedNet and their platform. However, it could provide more context on the specific services offered to the customer and the financial details of the agreement.
Noise Level: 3
Noise Justification: The article provides relevant information about a company’s new contract with an unnamed global top-10 medical technology provider, but lacks in-depth analysis or exploration of the implications for the industry or the specific partner company. It also does not offer much actionable insights or new knowledge beyond the basic facts.
Public Companies: OneMedNet (N/A)
Private Companies: global top-10 medical technology provider,U.S.-based medical technology company
Key People: Adam L. Cataldo (Author)

Financial Relevance: Yes
Financial Markets Impacted: Stock market
Financial Rating Justification: The article discusses a company’s stock performance and a new contract with a global medical technology provider impacting the company’s shares, which affects financial markets and companies.
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Extreme Rating Justification: No extreme event mentioned in the article

Reported publicly: www.marketwatch.com